Nicotinic acetylcholine receptors of muscles and nerves: Comparison of their structures, functional roles, and vulnerability to pathology

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 41-52

  Lindstrom, Jon M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AChR; Muscle; Myasthenia gravis (MG); Neuron; Nicotine

Indexed keywords

ALPHA BUNGAROTOXIN; CONOTOXIN; EPIBATIDINE; MORPHINE; NERVE GAS; NICOTINE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; SNAKE VENOM;

AMINO ACID SEQUENCE; AUTOIMMUNITY; BINDING SITE; BRONCHUS MUCOSA; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONFERENCE PAPER; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG POTENCY; DYSAUTONOMIA; EATON LAMBERT SYNDROME; EPILEPSY; FUNCTIONAL ASSESSMENT; GENETIC DISORDER; IMMUNE RESPONSE; IMMUNOGENICITY; KERATINOCYTE; MUSCLE; MUTATION; MYASTHENIA GRAVIS; NERVE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; SEQUENCE ANALYSIS; SKIN DISEASE; STRUCTURE ANALYSIS; TOBACCO DEPENDENCE;

BRONCHUS; NICOTIANA TABACUM; SERPENTES;

EID: 0141748121     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.007     Document Type: Conference Paper

References (65)

1. KARLIN, A. 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 3: 102-114.
2. GUTTER, T. & J-P. CHANGEUX. 2001. Nicotinic receptors in wonderland. Trends Biochem. Sci. 26: 459-463.
3. LINDSTROM, J. 2000. The structures of neuronal nicotinic receptors. Handb. Exp. Pharmacol. 144: 101-162.
4. SMIT, A., N. SYED, D. SCHAAP et al. 2001. A glia-derived acetylcholine-binding protein that modulates synaptic transmission. Nature 411: 261-268.
5. BREJC, K., W. VAN DUK, R. KLAASSEN et al. 2001. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 411: 269-276.
6. HAREL, M., R. KASHER, A. NICHOLAS et al. 2001. The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex peptide between α bungarotoxin and a mimotope. Neuron 32: 265-275.
7. FU, D-X. & S. SINE. 1996. Asymmetric contribution of the conserved disulfide loop to subunit oligomerization and assembly of the nicotinic acetylcholine receptor. J. Biol. Chem. 271: 31479-31484.
8. WELLS, G., R. ANAND, F. WANG et al. 1998. Water soluble nicotinic acetylcholine receptor formed by α7 subunit extracellular domains. J. Biol. Chem. 273: 964-973.
9. MIYAZAWA, A., Y. FUJIYOSHI, M. STOWELL et al. 1999. Nicotinic acetylcholine receptor at 4.6 Å resolution: transverse tunnels in the channel wall. J. Mol. Biol. 288: 765-786.
10. MAIMONE, M. & J. MERLIE. 1993. Interaction of the 43 kd postsynaptic protein with all subunits of the muscle nicotinic acetylcholine receptor. Neuron 11: 53-66.
11. WILLIAMS, B., M. TEMBURNI, M. LEVY et al. 1998. The long internal loop of the α3 subunit targets in AChRs to subdomains within individual synapses on neurons in vivo. Nat. Neurosci. 1: 557-562.
12. PARADISO, K., J. ZHANG, S. STEINBACH et al. 2001. The C-terminus of the human nicotinic α4β2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci. 21: 6561-6568.
13. IBANEZ-TALLON, I., J. MIWA, H-L. WANG et al. 2002. Novel modulation of neuronal nicotinic acetylcholine receptors by association with endogenous prototoxin lynx 1. Neuron 33: 893-903.
14. FENSTER, C., M. BECKMAN, J. PARKER et al. 1999. Regulation of α4β2 nicotinic receptor desensitization by calcium and protein kinase C. Mol. Pharmacol. 55: 432-443.
15. ENGEL, A. 1994. The neuromuscular junction. In Myology. Second edition. Vol. 1, pp. 261-302. McGraw-Hill. New York.
16. MCINTOSH, J.M. 2000. Toxin antagonists of the neuronal nicotinic acetylcholine receptor. Handb. Exp. Pharmacol. 144: 455-476.
17. GUNDERSON, C., C. LEHMANN, F. SIDELL et al. 1992. Nerve agents: a review. Neurology 42: 946-950.
18. ENGEL, A., K. OHNO & S. SINE. 2002. The spectrum of congenital myasthenic syndromes. Mol. Neurobiol. In press.
19. LINDSTROM, J. 2000. Acetylcholine receptors and myasthenia. Muscle Nerve 23: 453-477.
20. MATSUDA, K., S. BUCKINGHAM, D. KLEIER et al. 2001. Neonicotinoids: insecticides acting on nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 22: 573-580.
21. XU, W., S. GELBER, A. ORR-URTREGER et al. 1999. Megacystis, mydriasis, and ion channel defect in mice lacking the α3 neuronal nicotinic receptor. Proc. Natl. Acad. Sci. USA 96: 5746-5751.
22. JONES, S., J. BOLAN & S. WONNACOTT. 2001. Presynaptic localization of the nicotinic acetylcholine receptor β2 subunit immunoreactivity in rat nigrostriatal dopaminergic neurons. J. Comp. Neurol. 439: 235-247.
23. ALKONDON, M., E. PEREIRA, H. EISENBERG et al. 1999. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CAI interneurons in rat hippocampal slices. J. Neurosci. 19: 2693-2705.
24. KULAK, J., J. MCINTOSH & M. QUIK. 2002. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in α conotoxin M11 sites. Mol. Pharmacol. 61: 230-238.
25. SHOOP, R., E. ESQUINAZI, N. YAMADA et al. 2002. Ultrastructure of a somatic spine mat for nicotinic signaling in neurons. J. Neurosci. 22: 748-756.
26. ZOLI, M., A. JANSSON, E. SYKOVA et al. 1999. Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20: 142-150.
27. GRANDO, S. 2001. Receptor mediated action of nicotine in human skin. Int. J. Dermatol. 40: 691-693.
28. KAWASHIMA, K. & T. FUJII. 2000. Extraneuronal cholinergic system in lymphocytes. Pharmacol. Ther. 86: 29-48.
29. FISCHER, V., S. REINHARDT, E. ALBUQUERQUE et al. 1999. Expression of functional alpha 7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur. J. Neurosci. 11: 2856-2864.
30. ORR-URTREGER, A., F. GOLDNER, M. SAEKI et al. 1997. Mice deficient in the α7 neuronal nicotinic acetylcholine receptor lack α bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17: 9165-9171.
31. CONROY, W. & D. BERG. 1995. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J. Biol. Chem. 270: 4424-4431.
32. LENA, C., M. DE KERCHOVE D'EXAERDE, M. CORDERO-ERAUSQIN et al. 1999. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc. Natl. Acad. Sci. USA 96: 12126-12131.
33. MISSIAS, A., J. MUDD, J. CUNNINGHAM et al. 1997. Deficient development and maintenance of postsynaptic specializations in mutant mice lacking an "adult" acetylcholine receptor subunit. Development 124: 5075-5086.
34. STEINLEIN, O. 2000. Neuronal nicotinic receptors in human epilepsy. Eur. J. Pharmacol. 393: 243-247.
35. DE FUSCO, M., A. BECCHETTI, A. PATRIGNANI et al. 2000. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet. 26: 275-276.
36. PHILLIPS, H., I. FAVRE, M. KIRKPATRICK et al. 2001. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet. 68: 225-231.
37. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J. Neurosci. 17: 9035-9047.
38. PICCIOTTO, M., B. CALDARONE, S. KING et al. 2002. Nicotinic receptors in the brain: links between molecular biology and behavior. Neuropsychopharmacology 22: 451-465.
39. XU, W., A. ORR-URTREGER, F. NIGRO et al. 1999. Multiorgan autonomic dysfunction in mice lacking the β2 and β4 subunits of neuronal nicotinic acetylcholine receptors. J. Neurosci. 19: 9298-9305.
40. RICHARDSON, C., J. MORGAN, B. JASANI et al. 2001. Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the α3 nicotinic acetylcholine receptor subunit. Gastroenterology 121: 350-357.
41. CHAMPTIAUX, N., Z-Y. HAN, A. BESSIS et al. 2002. Distribution and pharmacology of α6-containing nicotinic acetylcholine receptors analyzed with mutant mice. J. Neurosci. 22: 1207-1208.
42. VETTER, D., M. LIBERMAN, J. MANN et al. 1999. Role of α9 nicotinic ACh receptor subunits in the development and function of cochlear efferent innervation. Neuron 23: 93-103.
43. LUSTIG, L., H. PENG, H. HIEL et al. 2001. Molecular cloning and mapping of the human nicotinic acetylcholine receptor α10(CHRNA10). Genomics 73: 272-283.
44. ELGOYHEN, A., D. VETTER, E. KATZ et al. 2001. Alpha 10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl. Acad. Sci. USA 98: 3501-3506.
45. LABARCA, C., J. SCHWARTZ, P. DESHPANDE et al. 2001. Point mutant mice with hypersensitive α4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc. Natl. Acad. Sci. USA 98: 2786-2791.
46. ORR-URTREGER, A., R. BROIDE, M. KASTEN et al. 2000. Mice homozygous for the L250T mutation in the α7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth. J. Neurochem. 74: 2154-2166.
47. SHELTON, G. & J. LINDSTROM. 2001. Spontaneous remission in canine myasthenia gravis: implications for assessing human therapies. Neurology 57: 2139-2141.
48. TZARTOS, S., T. BARKAS, M. CUNG et al. 1998. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163: 89-120.
49. SAEDI, M., R. ANAND, W. CONROY et al. 1990. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett. 267: 55-59.
50. BEROUKHIM, R. & N. UNWIN. 1995. Three dimensional location of the main immunogenic region of the acetylcholine receptor. Neuron 15: 323-331.
51. VERNINO, S., P. LOW, R. FEALEY et al. 2000. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Engl. J. Med. 343: 847-855.
52. WANG, F., M. NELSON, A. KURYATOV et al. 1998. Chronic nicotine treatment upregulates human α3β2, but not α3β4 AChRs stably transfected in human embryonic kidney cells. J. Biol. Chem. 273: 28721-28732.
53. LAVER, W., G. AIR, R. WEBSTER et al. 1990. Epitopes on protein antigens: misconceptions and realities. Cell 61: 553-556.
54. KONTON, M., D. LEONIDAS, E. VATZAKI et al. 2000. The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur. J. Biochem. 267: 2389-2396.
55. POULAS, K., E. ELIOPOULAS, E. VATZAKI et al. 2001. Crystal structure of Fab 198, an efficient protector of the acetylcholine receptor against myasthenogenic antibodies. Eur. J. Biochem. 268: 3685-3693.
56. GRANDO, S. 2000. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology 201: 290-295.
57. DRACHMAN, D. 1994. Myasthenia gravis. N. Engl. J. Med. 330: 1791-1810.
58. PETO, R., A. LOPEZ, J. BOUHAM et al. 1992. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 389: 1268-1278.
59. DANI, J., D. JI & F-M. ZHOU. 2001. Synaptic plasticity and nicotine addiction. Neuron 31: 349-352.
60. LLOYD, K. & M. WILLIAMS. 2000. Neuronal nicotinic acetylcholine receptors as novel drug targets. J. Pharmacol. Exp. Ther. 292: 461-467.
61. LEUTJE, C. & J. PATRICK. 1991. Both α and β subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11: 837-845.
62. BENOWITZ, N. 1996. Pharmacology of nicotine: addiction and therapeutics. Annu. Rev. Pharmacol. Toxicol. 36: 597-613.
63. LIU, Q., H. KAWAL & D. BERG. 2001. β amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons. Proc. Natl. Acad. Sci. USA 98: 4734-4739.
64. 1-42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110: 199-211.
65. LEONARD, S., L. ADLER, K. BENHAMMOU et al. 2001. Smoking and mental illness. Pharmacol. Biochem. Behav. 70: 561-570.